Page last updated: 2024-09-03

1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine and imipramine

1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine has been researched along with imipramine in 7 studies

Compound Research Comparison

Studies
(1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine)
Trials
(1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine)
Recent Studies (post-2010)
(1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine)
Studies
(imipramine)
Trials
(imipramine)
Recent Studies (post-2010) (imipramine)
6201410,3201,359801

Protein Interaction Comparison

ProteinTaxonomy1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine (IC50)imipramine (IC50)
Solute carrier family 22 member 2Homo sapiens (human)0.6
Solute carrier family 22 member 1 Homo sapiens (human)7.95
Voltage-dependent L-type calcium channel subunit alpha-1CCavia porcellus (domestic guinea pig)8.3
Voltage-dependent L-type calcium channel subunit alpha-1FHomo sapiens (human)8.3
5-hydroxytryptamine receptor 2CRattus norvegicus (Norway rat)0.044
Muscarinic acetylcholine receptor M5Rattus norvegicus (Norway rat)0.3
Cytochrome P450 2D6Homo sapiens (human)0.0051
D(2) dopamine receptorHomo sapiens (human)0.41
5-hydroxytryptamine receptor 2ARattus norvegicus (Norway rat)0.044
Alpha-1B adrenergic receptorRattus norvegicus (Norway rat)0.16
Sphingomyelin phosphodiesteraseHomo sapiens (human)5
DRattus norvegicus (Norway rat)2.0992
D(3) dopamine receptorRattus norvegicus (Norway rat)0.81
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)0.044
Alpha-2B adrenergic receptorRattus norvegicus (Norway rat)3.3884
Alpha-2C adrenergic receptorRattus norvegicus (Norway rat)3.3884
Alpha-2A adrenergic receptorRattus norvegicus (Norway rat)3.3884
Alpha-1D adrenergic receptorRattus norvegicus (Norway rat)0.16
Sodium-dependent noradrenaline transporter Homo sapiens (human)0.074
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)3.3884
D(1B) dopamine receptorRattus norvegicus (Norway rat)0.81
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.22
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)0.044
5-hydroxytryptamine receptor 1DRattus norvegicus (Norway rat)0.044
D(4) dopamine receptorRattus norvegicus (Norway rat)0.81
5-hydroxytryptamine receptor 1FRattus norvegicus (Norway rat)0.044
5-hydroxytryptamine receptor 2BRattus norvegicus (Norway rat)0.044
5-hydroxytryptamine receptor 6Rattus norvegicus (Norway rat)0.044
Histamine H1 receptorRattus norvegicus (Norway rat)0.0001
Sodium-dependent serotonin transporterHomo sapiens (human)0.0074
Sodium-dependent serotonin transporterRattus norvegicus (Norway rat)0.81
5-hydroxytryptamine receptor 7 Rattus norvegicus (Norway rat)0.044
5-hydroxytryptamine receptor 5ARattus norvegicus (Norway rat)0.044
5-hydroxytryptamine receptor 5BRattus norvegicus (Norway rat)0.044
Histamine H1 receptorHomo sapiens (human)0.027
Sodium channel protein type 1 subunit alphaHomo sapiens (human)3.6
Sodium channel protein type 4 subunit alphaHomo sapiens (human)3.6
5-hydroxytryptamine receptor 3ARattus norvegicus (Norway rat)0.044
Alpha-1A adrenergic receptorRattus norvegicus (Norway rat)0.16
Histamine H2 receptorCavia porcellus (domestic guinea pig)1.9
D(2) dopamine receptorRattus norvegicus (Norway rat)0.81
Sodium channel protein type 7 subunit alphaHomo sapiens (human)3.6
Voltage-dependent L-type calcium channel subunit alpha-1D Homo sapiens (human)8.3
Potassium voltage-gated channel subfamily H member 2Homo sapiens (human)3.3913
Voltage-dependent L-type calcium channel subunit alpha-1SHomo sapiens (human)8.3
Voltage-dependent L-type calcium channel subunit alpha-1CHomo sapiens (human)8.3
Sodium channel protein type 5 subunit alphaHomo sapiens (human)3.6
Sodium channel protein type 9 subunit alphaHomo sapiens (human)3.6
5-hydroxytryptamine receptor 4 Rattus norvegicus (Norway rat)0.044
Multidrug and toxin extrusion protein 1Homo sapiens (human)10
Sodium channel protein type 2 subunit alphaHomo sapiens (human)3.6
5-hydroxytryptamine receptor 3BRattus norvegicus (Norway rat)0.044
Sodium channel protein type 3 subunit alphaHomo sapiens (human)3.6
Solute carrier family 22 member 2Rattus norvegicus (Norway rat)9.9
Sodium channel protein type 11 subunit alphaHomo sapiens (human)3.6
Sodium channel protein type 8 subunit alphaHomo sapiens (human)3.6
TransporterRattus norvegicus (Norway rat)0.81
Sodium channel protein type 10 subunit alphaHomo sapiens (human)3.6

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (14.29)18.2507
2000's1 (14.29)29.6817
2010's5 (71.43)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG1
Colau, D; Dolusić, E; Frédérick, R; Larrieu, P; Masereel, B; Moineaux, L; Pilotte, L; Pochet, L; Stroobant, V; Van den Eynde, B; Wouters, J1
Anzini, M; Brogi, S; Butini, S; Campiani, G; Cappelli, A; Caselli, G; Castriconi, F; Gemma, S; Giordani, A; Giorgi, G; Giuliani, G; Lanza, M; Letari, O; Makovec, F; Manini, M; Mennuni, L; Valenti, S1
Belyakov, S; Dambrova, M; Kazoka, H; Kuznecovs, J; Lebedev, A; Liepinsh, E; Mishnev, A; Orlova, N; Ponomaryov, Y; Vavers, E; Veinberg, G; Vikainis, S; Vilskersts, R; Vorona, M; Zvejniece, L1
Bednarski, M; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pękala, E; Powroźnik, B; Słoczyńska, K; Walczak, M; Waszkielewicz, AM; Żesławska, E1
Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E1
Attali, G; Gil-Ad, I; Rehavi, M; Weizman, A1

Other Studies

7 other study(ies) available for 1-(1-(2-benzo(b)thienyl)cyclohexyl)piperidine and imipramine

ArticleYear
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
    Journal of medicinal chemistry, 2008, Nov-27, Volume: 51, Issue:22

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship

2008
Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
    Journal of medicinal chemistry, 2011, Aug-11, Volume: 54, Issue:15

    Topics: Animals; Antineoplastic Agents; Biological Availability; Cell Line; Drug Design; Enzyme Inhibitors; Humans; Immunologic Factors; Indoles; Kinetics; Mice; Neoplasms; Structure-Activity Relationship; Tryptophan Oxygenase

2011
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds.
    European journal of medicinal chemistry, 2013, Volume: 63

    Topics: Animals; Area Under Curve; Humans; Intestinal Absorption; Ligands; Male; Metabolic Clearance Rate; Models, Chemical; Models, Molecular; Molecular Structure; Protein Binding; Protein Structure, Tertiary; Pyrrolidinones; Radioligand Assay; Receptor, Serotonin, 5-HT1A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship

2013
Synthesis and biological evaluation of 2-(5-methyl-4-phenyl-2-oxopyrrolidin-1-yl)-acetamide stereoisomers as novel positive allosteric modulators of sigma-1 receptor.
    Bioorganic & medicinal chemistry, 2013, May-15, Volume: 21, Issue:10

    Topics: Acetamides; Allosteric Regulation; Animals; Rats; Rats, Wistar; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Structure-Activity Relationship

2013
Design, physico-chemical properties and biological evaluation of some new N-[(phenoxy)alkyl]- and N-{2-[2-(phenoxy)ethoxy]ethyl}aminoalkanols as anticonvulsant agents.
    Bioorganic & medicinal chemistry, 2016, Apr-15, Volume: 24, Issue:8

    Topics: Amino Alcohols; Animals; Anticonvulsants; Chemistry, Physical; Dose-Response Relationship, Drug; Drug Design; Epilepsy; Male; Mice; Microsomes, Liver; Molecular Structure; Pilocarpine

2016
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
    Bioorganic & medicinal chemistry, 2017, 01-15, Volume: 25, Issue:2

    Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship

2017
Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters.
    Brain research, 1997, May-09, Volume: 756, Issue:1-2

    Topics: Animals; Brain; Carrier Proteins; Dopamine Agonists; Dopamine Plasma Membrane Transport Proteins; Estradiol; Female; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Ovariectomy; Phencyclidine; Progesterone; Rats; Rats, Inbred Strains; Serotonin Plasma Membrane Transport Proteins

1997